Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Candel Therapeutics, Inc. (CADL) had Weighted-Average Shares Outstanding (Basic) of 51.49M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-4.80M |
|
-- |
|
-- |
|
$11.18M |
|
$-11.18M |
|
$6.38M |
|
$-4.80M |
|
$-4.80M |
|
$-4.80M |
|
$-4.80M |
|
$-4.80M |
|
$-4.80M |
|
$-11.18M |
|
$-10.94M |
|
|
Weighted-Average Shares Outstanding (Basic) |
51.49M |
51.49M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$103.61M |
|
$1.66M |
|
$2.36M |
|
$105.97M |
|
$14.71M |
|
$0.94M |
|
$1.04M |
|
$15.76M |
|
$90.21M |
|
$90.21M |
|
$90.21M |
|
54.89M |
|
| Cash Flow Statement Financials | |
$-17.51M |
|
$-0.03M |
|
$15.57M |
|
$102.92M |
|
$100.95M |
|
$-1.97M |
|
$1.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.04 |
|
-- |
|
-- |
|
0.01 |
|
0.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.32% |
|
-5.32% |
|
-4.53% |
|
-5.26% |
|
$1.64 |
|
$-0.34 |
|
$-0.34 |
|